Earlier this afternoon, Mirum Pharmaceuticals, Inc. issued a press release reporting our fourth quarter and full year 2025 financial results. Copies of the press release and our SEC filings are ...
As Washington once again raises the prospect of confrontation with Tehran, questions about U.S. intentions—and the limits of ...
Resideo Technologies, Inc. ( REZI) Q4 2025 Earnings Call February 24, 2026 5:00 PM EST ...